Showing results (551-560 of 565) with videos related to
Sort By:
Pageof 57
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 29, 1998
[Pharmaceutical and pharmacological development of antitumor prostaglandins]S Fukushima, S Kishimoto, Y Takeuchi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2009
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxelI Sekine, Y Ichinose, Y Nishiwaki, et al.Circulation|August 29, 2001
Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutaseS Negoro, K Kunisada, Y Fujio, et al.Plastic and Reconstructive Surgery|October 8, 1999
Comparison of innervated and noninnervated free flaps in oral reconstructionY Kimata, K Uchiyama, S Ebihara, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[A patient with unresectable cancer of pancreas head, effectively treated by a local injection of the mixture of OK-432, fibrinogen and thrombin]K Takekuni, M Sakon, S Kishimoto, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[A patient with hepatocellular carcinoma originating from the caudate lobe, who underwent hepatectomy following microwave coagulation therapy]S Kishimoto, M Sakon, K Umeshita, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[A patient with pancreatic acinar cell carcinoma, effectively treated by the infusion chemotherapy through hepatic artery using 5-FU, CDDP and MMC]M Sakon, H Osato, S Kishimoto, et al.British Journal of Cancer|February 20, 2008
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)K Tamura, I Okamoto, T Kashii, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day scheduleN Masuda, K Matsui, N Yamamoto, et al.Japanese Journal of Clinical Oncology|June 24, 1999
A large maxillofacial prosthesis for total mandibular defect: a case reportY Ota, S Ebihara, W Ooyama, et al.Pageof 57